2022 Bipolar disorder Genetics and mental health 
Psychiatric Times
JULY 1, 2025
SHOW MORE The FDA will update ADHD medication labels, warning of weight loss risks in children under 6, urging careful monitoring by health care professionals. Healthcare professionals should monitor weight and growth in young patients on these medications and consider alternative treatments if adverse effects occur.
Mad in America
JULY 10, 2025
W hen I first saw Laura Delano’s story was being published by Penguin, a major publisher, I knew that we were on the brink of change by way of the public narrative around mental health in the west. Like Laura, I was diagnosed with bipolar disorder at age seventeen.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Mad in America
OCTOBER 17, 2024
Unbalanced, for instance, in the sense that much emphasis is placed on brain and genetic studies that to this day have cost billions of dollars, while showing only very small associations—not providing any basis for biological screening. Genetic studies are also the cause of many misunderstandings.
Mad in America
JANUARY 20, 2024
In the article, Torrey reviews the history of the Human Genome Project, their hopes for identifying the genetic basis for schizophrenia, and how those hopes have been dashed by the complete failure to find anything of the sort. Torrey is a psychiatrist and a researcher on schizophrenia and bipolar disorder.
Mad in America
MAY 3, 2025
Establishment psychiatry does acknowledge that emotional suffering and behavioral disturbanceswhat it calls mental illnesseshave biological-psychological-social roots. medical schools. Worldwide, there are parallels to U.S.
Mad in America
OCTOBER 21, 2023
Thomas Insel, director of the National Institute of Mental Health (NIMH) from 2002-2015, acknowledged in 2011, “Whatever we’ve been doing for five decades, it ain’t working. adults now takes an antidepressant”; however, Time continued, “Mental health is getting worse by multiple metrics. As of late 2022, just 31% of U.S.
Mad in America
NOVEMBER 6, 2023
667 In an NIMH study of 547 patients that compared six-year outcomes for depressed people treated for the disorder and those who eschewed medical treatment, the treated patients were three times more likely than untreated ones to suffer a cessation of their principal social role and nearly seven times more likely to become incapacitated.
Expert insights. Personalized for you.
98 
Let's personalize your content